BIO 300 Oral Suspension in Previously Hospitalized Long COVID Patients

Clinical trial NCT04482595 · UNKNOWN

Trial details

NCT number: NCT04482595
Sponsor: Humanetics Corporation
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

COVID-19 Long COVID Pulmonary Fibrosis Post-acute Respiratory Complications of COVID-19

Start date: 2020-11-11
Primary completion: 2024-07-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.